[RS4] The influence of UK risk-sharing models (patient access schemes) on payers in Germany and the Netherlands. A qualitative research approach

[RS4] The influence of UK risk-sharing models (patient access schemes) on payers in Germany and the Netherlands. A qualitative research approach

2010 Value in health

Guhl, N. | Kolominsky-Rabas, P. | Toumi, M. | Volume: 13, Issue: 7, Pages: A242, Germany, Market access, market access agreements, model,

OBJECTIVES: The number of risk-sharing schemes in the UK increased signifi cantly
since the introduction of the new Pharma Pricing and Regulation Scheme (PPRS) in
early 2009. Other health-care systems seem to follow. The objective is to investigate
via qualitative research if payers in Germany and The Netherlands are infl uenced by
UK decisions, if there are any preferred schemes, e.g., fi nance-based versus valuebased,
and if the outcome for payers and manufacturers are comparable among the
countries concerned. METHODS: A comprehensive questionnaire was designed, validated,
and translated into German and Dutch. Decision-makers at various levels
involved in the implementation of risk-sharing models in Germany and The Netherlands
were interviewed face to face. The interviews lasted approximately 60 minutes
and were held in their mother language. All interviews were recorded and a total of
n = 10 interviews were conducted. RESULTS: German payers especially sick funds
seem to be more open to adopt risk-sharing models than their colleagues in The
Netherlands. There is a clear tendency in both countries that UK risk-sharing schemes
have an infl uence on the decision-making process; however, most payers responded
that there must be some adaptations to local needs. CONCLUSIONS: Risk-sharing
models will become increasingly popular in the near future especially in Germany.
Companies have to be prepared especially in therapeutic areas like oncology to follow
this route as a way of market access. Although risk-sharing models have been introduced
in other European countries before 2009, the UK models seem to rep